Impact of Providing Nursing Support on Parental Stress Related to Preoperative Care of a Newborn with Hirschsprung's Disease

NCT ID: NCT06650683

Last Updated: 2024-10-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-08-14

Study Completion Date

2026-02-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Impact of providing nursing support on parental stress related to preoperative care of a newborn with Hirschsprung's disease

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hirschsprung Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SEQUENTIAL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

With Hospitalisation at Home (HAH)

families living in Marseille, whose parents will be able to return home under the supervision of nursery nurses from the pediatric HAH.

Group Type EXPERIMENTAL

Pediatric HAH

Intervention Type BEHAVIORAL

Pediatric HAH nursing support for home nursery care provided by parents as part of their child's disease.

Without Hospitalisation at Home (HAH)

Families living outside Marseille whose parents will have to carry out nursings at home independently, without the help of pediatric HAH.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pediatric HAH

Pediatric HAH nursing support for home nursery care provided by parents as part of their child's disease.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Families (one or two parents) with a newborn or infant under 2 months with confirmed or suspected Hirschsprung disease, for whom nursings are effective and performed 1 to 2 times a day while waiting for surgery.
* With a possible return home before surgery
* With an information leaflet and non-opposition form signed by one or both parent(s) or by the legal representative.

Exclusion Criteria

* The absence of daily nursings
* Initial ineffectiveness of nursings requiring a digestive stoma
* Failure to return home before surgery
* Refusal of one or both parent(s) or legal representative(s)
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique Hopitaux De Marseille

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

APHM

Marseille, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Melanie Boulanger

Role: CONTACT

+33491381245

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Melanie Boulanger

Role: primary

+33491381245

Melanie Boulanger

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-A02696-37

Identifier Type: OTHER

Identifier Source: secondary_id

RCAPHM22_0037

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Delivery Room Skin-to-skin Study
NCT01959737 COMPLETED NA